Utilizing AI for Medication Management
Drug Topics
JULY 13, 2023
Pharmacists can utilize AI for medication management and to prevent medication errors.
Drug Topics
JULY 13, 2023
Pharmacists can utilize AI for medication management and to prevent medication errors.
PharmaVoice
JULY 13, 2023
Besides its popularity as a weight loss drug, Ozempic and treatments like it are being investigated for Alzheimer’s, liver disease and other surprising indications.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JULY 13, 2023
The approval of norgestrel (Opill) is expected to help reduce barriers to access by allowing people to obtain the medication without needing to see a health care provider.
Pharmacy Times
JULY 13, 2023
The approval of norgestrel tablets (Opill) could open the door to other prescription-to-OTC contraceptive switches, although that remains to be seen as other pharmaceutical companies weigh their options.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
JULY 13, 2023
The news comes almost 2 weeks after Cyltezo’s entrance into the US biosimilars market as the first commercially available and FDA-approved interchangeable adalimumab biosimilar.
Pharmacy Times
JULY 13, 2023
These study results may inform clinical practice strategies this year and beyond.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
JULY 13, 2023
Impact of healthy eating was especially evident in countries where consumption of these foods is low, which elevates the risk for cardiovascular disease, including heart attacks and strokes.
STAT
JULY 13, 2023
By going down to the molecular level, doctors have uncovered a way to treat tumors caused by a rare brain cancer using medicines that already exist. Two cancer drugs — currently approved for the treatment of melanoma — were able to treat a rare type of brain cancer called PCP, or papillary craniopharyngioma, researchers reported in a study published Thursday in the New England Journal of Medicine.
Pharmacy Times
JULY 13, 2023
Expanding pharmacist–patient care services to include vaccine promotion and administration within ambulatory clinics is an example of the expanding role of pharmacists and their contribution to primary care practice.
STAT
JULY 13, 2023
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
JULY 13, 2023
MicroRNA has shown the potential to more effectively and accurately identify C. difficile infections and manage it after diagnosis.
STAT
JULY 13, 2023
WASHINGTON — Aspartame, the popular artificial sweetener in diet sodas and chewing gums, may possibly cause cancer — but the risk appears to be very low for occasional consumers of these products, according to two reports released Thursday evening by the World Health Organization. The first report , penned by the WHO’s International Agency for Research on Cancer (IARC), found “limited evidence” that aspartame may cause liver cancer.
Pharmacy Times
JULY 13, 2023
Irreversible Bruton tyrosine kinase inhibitor produces positive results in patients with relapsed/refractory marginal zone lymphoma.
STAT
JULY 13, 2023
It’s been a year since the U.S. launched its 988 national mental health hotline — and while the service is still dealing with logistical challenges , its biggest issue may be persuading more Americans to make use of it. Only 33% of Americans are at least somewhat familiar with the number and the service it provides, according to a survey of more than 2,000 adults conducted by Ipsos and the National Alliance on Mental Illness (NAMI) conducted in June 2023.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
JULY 13, 2023
Evidence remains limited for specific therapies to treat the disease, but new clinical trials are ongoing.
STAT
JULY 13, 2023
In May, just before Pride Month, the Centers for Disease Control and Prevention released news worth celebrating: 2021 saw the lowest numbers of new HIV diagnoses in decades. New HIV infections were down 12% from 2017 to 2021, thanks to successful prevention efforts, including PrEP. The end of the epidemic may finally be in our grasp. Prevention methods now include a medication called PrEP (for pre-exposure prophylaxis), and uptake has never been higher.
Pharmacy Times
JULY 13, 2023
Chronic or recurring episodes can lead to other complications.
STAT
JULY 13, 2023
In a highly anticipated move, the Food and Drug Administration on Thursday approved the first over-the-counter birth control pill , a decision that could transform the way contraception is delivered in the United States. For the first time, people will now be able to readily purchase birth control online and at pharmacies, convenience stores, and grocery stores without a prescription, a requirement that has been seen as a hurdle to greater access to contraception.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
JULY 13, 2023
A potential new drug therapy found from blood proteins could improve outcomes for individuals diagnosed with long COVID.
STAT
JULY 13, 2023
Health systems drowning in messages from patients are grasping for new ways to manage the deluge — including charging for especially time-consuming responses. In recent months, health systems including Cleveland Clinic and University of Washington have trotted out new billing policies for when patient portal questions require more than just a few minutes of a provider’s time — an attempt to compensate for staff time spent while also stanching the breakneck response pace pati
European Pharmaceutical Review
JULY 13, 2023
In EPR’s Future of Bio/Pharmaceutical Analysis online summit last month, Lonza’s Associate Director of R&D discussed the benefits and challenges of using process analytical technology (PAT) in biologics manufacturing. The CDMO’s Carrie Mason shared that PAT, “takes a little bit more time and more effort and more capital to set up in the beginning, but once you get it up and running it’s very continuous and it should continue to provide results for a long time”.
STAT
JULY 13, 2023
“C ode yellow!” someone screamed. I dipped in and out of consciousness, in and out of panic.
Fierce Healthcare
JULY 13, 2023
Approximately 22% of gross Medicare Part D spending can be attributed to 10 top-selling prescription drugs, according to analysis from KFF. | A new analysis shows a small number of prescription drugs disproportionately make up Medicare Part D spending.
STAT
JULY 13, 2023
WASHINGTON — Sen. Chuck Schumer (D-N.Y.), the most powerful person in the U.S. Senate, wants the Food and Drug Administration to investigate the increasingly popular energy drink brand Prime. But it’s unclear what grounds the FDA would have to single out the company in the near future, or what the agency could really do on its own if it wanted to take serious actions against its co-founder, social media star and professional wrestler Logan Paul.
Fierce Healthcare
JULY 13, 2023
The Centers for Medicare & Medicaid Services (CMS) is recommending preexposure prophylaxis (PrEP) with oral or injectable antiretroviral therapy to people at risk of HIV without patient cost sh | A new proposal would allow Medicare beneficiaries to protect themselves against HIV without cost-sharing through preexposure prophylaxis and antiretroviral therapy.
STAT
JULY 13, 2023
After leaving his post as the head of research at Bristol Myers Squibb, Rupert Vessey is joining venture firm Flagship Pioneering. Vessey will become an executive partner and chief scientist at Flagship starting July 31, according to a press release. He will work with the teams at Flagship that create new startups, helping them with science and R&D strategies.
Fierce Healthcare
JULY 13, 2023
Hospital merger and acquisition deal volume has returned to pre-pandemic levels as of the second quarter of 2023, according to a new roundup report. | Twenty new hospital merger and acquisition deals were unveiled during the second quarter of 2023, the most since 2018.
STAT
JULY 13, 2023
In the 1930s, the U.S. government introduced the practice of redlining — categorizing neighborhoods based on the ethnic and racial backgrounds of the people who lived there, with areas primarily occupied by people of color identified as high-risk for mortgage lenders. The policy led to further housing segregation and decades of disinvestment in health care, schools, and other basic services and infrastructure, taking a disproportionate toll on Black communities.
Pharma Marketing Network
JULY 13, 2023
When it comes to marketing your pharma business on Facebook, you may be wondering whether you should boost a post or create an ad. Both have their own advantages and disadvantages, so it’s important to choose the right option for your needs. Boosting a post is a quick and easy way to get more exposure for your content. When you boost a post, you’re essentially paying to increase its reach and visibility.
STAT
JULY 13, 2023
WASHINGTON — Congress is considering a must-pass pandemic preparedness bill that presents a good opportunity to fix the nation’s current drug shortages problem, which both parties want to do. But most indications are that lawmakers will let that opportunity pass them by. Although not new, drug shortages are now a crisis, with an increasing number of reports about cancer doctors having to ration chemotherapies and other drugs.
European Pharmaceutical Review
JULY 13, 2023
The field of immunotherapy is constantly evolving with the ultimate goal to develop new treatments that help the body’s immune system fight cancer. Immune cells, such as T cells and natural killer (NK) cells, have the inherent ability to combat diseases, including cancer, but are often inhibited by the body’s own suppressive mechanisms. Cancer immunotherapies such as checkpoint inhibitors (CPIs) were designed to counteract these.
STAT
JULY 13, 2023
WASHINGTON — A key Senate health care panel has developed a plan to tackle reforms to middlemen in the pharmacy drug payment system, according to bill text obtained by STAT. The draft legislation, authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho), includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers.
Let's personalize your content